New York Times Co
NYSE:NYT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
New York Times Co
NYSE:NYT
|
US |
|
Capricor Therapeutics Inc
F:4LN2
|
US |
|
V
|
Vext Science Inc
XMUN:VV5
|
CA |
Intrinsic Value
The intrinsic value for
New York Times Co (NYT) under the Base Case is 56.45 USD.
Compared with the current market price of 67.96 USD, the stock appears
Overvalued by 17% .
Do our valuations actually work? See backtest results .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for New York Times Co.
Fundamental Analysis
Revenue & Expenses Breakdown
New York Times Co
Earnings Waterfall
New York Times Co
The intrinsic value for
New York Times Co (NYT) under the Base Case is 56.45 USD.
Compared with the current market price of 67.96 USD, the stock appears Overvalued by 17% .